References
- Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19
severity: A literature review. Rev Med Virol 2021;31(1):1-10. doi:
10.1002/rmv.2146.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
doi: 10.1016/S0140-6736(20)30211-7.
- Jutzeler CR, Bourguignon L, Weis CV, et al. Comorbidities, clinical
signs and symptoms, laboratory findings, imaging features, treatment
strategies, and outcomes in adult and pediatric patients with
COVID-19: A systematic review and meta-analysis. Travel Med Infect
Dis. 2020;37:101825. doi: 10.1016/j.tmaid.2020.101825.
- WHO. COVID-19 Clinical management. Living guidance. 25 January 2021.
Accessed 5 May 2021. Available at
https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1.
- Yuce M, Filiztekin E, Ozkaya KG. COVID-19 diagnosis -A review of
current methods. Biosens Bioelectron. 2021;172:112752. doi:
10.1016/j.bios.2020.112752.
- Simsek Yavuz S, Unal S. Antiviral treatment of COVID-19. Turk J Med
Sci. 2020;50(SI-1):611-9. doi: 10.3906/sag-2004-145.
- COVID-19 guide. Available
at: https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf.
(accessed 20 May 2020).
- Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu AE. easyROC: an
interactive web-tool for ROC curve analysis using R language
environment. R J. 2016;8(2):213-30.
- Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is
positively associated with the severity of COVID-19. Ann Clin
Microbiol Antimicrob. 2020;19(1):18. doi: 10.1186/s12941-020-00362-2.
- Aksu K, Naziroğlu T, Özkan P. Factors determining COVID-19 pneumonia
severity in a country with routine BCG vaccination. Clin Exp Immunol.
2020 Nov;202(2):220-225. doi: 10.1111/cei.13507.
- Mousavi SA, Rad S, Rostami T, et al. Hematologic predictors of
mortality in hospitalized patients with COVID-19: a comparative study.
Hematology. 2020;25(1):383-8. doi: 10.1080/16078454.2020.1833435.
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute
respiratory distress syndrome and death in patients with coronavirus
disease 2019 pneumonia in Wuhan, China. JAMA Intern Med.
2020;180(7):934–43. doi:10.1001/jamainternmed.2020.0994.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet. 2020;395(10229):1054–62.
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically
ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. Lancet Respir
Med. 2020;8(5):475–81. doi:10.1016/S2213-2600(20)30079-5
- Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association
with mortality in patients with COVID-19. J Thromb Haemost.
2020;18(6):1469–72. doi: 10.1111/jth.14848.
- Xiang N, Havers F, Chen T, et al. Use of national pneumonia
surveillance to describe influenza A(H7N9) virus epidemiology, China,
2004-2013. Emerg Infect Dis. 2013;19(11):1784-90. doi:
10.3201/eid1911.130865.
- Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of
mortality due to COVID-19 based on an analysis of data of 150 patients
from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. doi:
10.1007/s00134-020-05991-x.
- Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT
during recovery from 2019 novel coronavirus (COVID-19) pneumonia.
Radiology. 2020;296(2):E55–E64. doi:10.1148/radiol.2020200370.
- Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and
thrombosis in patients with COVID-19. Lancet Haematol.
2020;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi:
10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet.
2020;395(10229):1038. Erratum in: Lancet. 2020;395(10229):1038.
- Yuan J, Zou R, Zeng L, et al. The correlation between viral clearance
and biochemical outcomes of 94 COVID-19 infected discharged patients.
Inflamm Res. 2020;69(6):599-606. doi: 10.1007/s00011-020-01342-0.
- He Z, Zhao C, Dong Q, et al. Effects of severe acute respiratory
syndrome (SARS) coronavirus infection on peripheral blood lymphocytes
and their subsets. Int J Infect Dis. 2005;9(6):323-30. doi:
10.1016/j.ijid.2004.07.014.
- Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet
Respir Med. 2020;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3.
- Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic,
biochemical and immune biomarker abnormalities associated with severe
illness and mortality in coronavirus disease 2019 (COVID-19): a
meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-28. doi:
10.1515/cclm-2020-0369.
- Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is
positively associated with the severity of COVID-19. Ann Clin
Microbiol Antimicrob. 2020;19(1):18. doi: 10.1186/s12941-020-00362-2.
- Pan F, Yang L, Li Y, et al. Factors associated with death outcome in
patients with severe coronavirus disease-19 (COVID-19): a case-control
study. Int J Med Sci. 2020;17(9):1281-92. doi: 10.7150/ijms.46614.